应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02137 腾盛博药-B
休市中 08-23 16:08:27
0.960
-0.010
-1.03%
最高
1.010
最低
0.940
成交量
108.95万
今开
0.980
昨收
0.970
日振幅
7.22%
总市值
7.01亿
流通市值
7.01亿
总股本
7.30亿
成交额
106.34万
换手率
0.15%
流通股本
7.30亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
腾盛博药-B盘中异动 早盘大幅上涨5.21%
市场透视 · 08-22 10:46
腾盛博药-B盘中异动 早盘大幅上涨5.21%
腾盛博药-B08月21日遭主力抛售72万元 环比增加800.00%
自选股智能写手 · 08-21
腾盛博药-B08月21日遭主力抛售72万元 环比增加800.00%
腾盛博药上半年亏损近三亿,但公司表示“不慌”
界面 · 08-20
腾盛博药上半年亏损近三亿,但公司表示“不慌”
《业绩》腾盛博药(02137.HK)中期亏损扩至2.81亿人民币
阿斯达克财经 · 08-20
《业绩》腾盛博药(02137.HK)中期亏损扩至2.81亿人民币
腾盛博药-B(02137)发布中期业绩 股东应占亏损2.81亿元 同比扩大47.71%
智通财经 · 08-19
腾盛博药-B(02137)发布中期业绩 股东应占亏损2.81亿元 同比扩大47.71%
腾盛博药-B(02137.HK)中期亏损扩大至2.83亿元
格隆汇 · 08-19
腾盛博药-B(02137.HK)中期亏损扩大至2.83亿元
腾盛博药-B盘中异动 下午盘股价大涨5.26%报1.000港元
自选股智能写手 · 08-19
腾盛博药-B盘中异动 下午盘股价大涨5.26%报1.000港元
腾盛博药-B(02137.HK)拟8月19日举行董事会会议批准中期业绩
格隆汇资讯 · 08-05
腾盛博药-B(02137.HK)拟8月19日举行董事会会议批准中期业绩
腾盛博药-B盘中异动 临近收盘股价大跌5.05%
自选股智能写手 · 08-05
腾盛博药-B盘中异动 临近收盘股价大跌5.05%
腾盛博药-B盘中异动 急速拉升6.06%
自选股智能写手 · 07-31
腾盛博药-B盘中异动 急速拉升6.06%
腾盛博药(02137):合作伙伴VBI启动重组程序
金吾财讯 · 07-31
腾盛博药(02137):合作伙伴VBI启动重组程序
腾盛博药(02137.HK)合作伙伴VBI启动重组程序
阿斯达克财经 · 07-31
腾盛博药(02137.HK)合作伙伴VBI启动重组程序
【腾盛博药-B(02137.HK)预计VBI的破产对公司运营及财务状况影响甚微】智通财经APP讯,腾盛博药-B(02137.
智通财经 · 07-31
【腾盛博药-B(02137.HK)预计VBI的破产对公司运营及财务状况影响甚微】智通财经APP讯,腾盛博药-B(02137.
腾盛博药-B(02137)预计VBI的破产对公司运营及财务状况影响甚微
智通财经 · 07-31
腾盛博药-B(02137)预计VBI的破产对公司运营及财务状况影响甚微
腾盛博药-B盘中异动 下午盘股价大跌7.62%
自选股智能写手 · 07-30
腾盛博药-B盘中异动 下午盘股价大跌7.62%
腾盛博药-B盘中异动 早盘股价大跌5.70%报1.010港元
自选股智能写手 · 07-24
腾盛博药-B盘中异动 早盘股价大跌5.70%报1.010港元
腾盛博药-B盘中异动 下午盘急速下挫5.49%
自选股智能写手 · 07-19
腾盛博药-B盘中异动 下午盘急速下挫5.49%
腾盛博药-B盘中异动 大幅拉升6.44%报1.140港元
自选股智能写手 · 07-17
腾盛博药-B盘中异动 大幅拉升6.44%报1.140港元
腾盛博药-B(02137)股价上升5.607%,现价港币$1.13
阿斯达克财经 · 07-17
腾盛博药-B(02137)股价上升5.607%,现价港币$1.13
腾盛博药-B(02137)上涨9.0%,报1.09元/股
金融界 · 07-12
腾盛博药-B(02137)上涨9.0%,报1.09元/股
公司概况
公司名称:
腾盛博药-B
所属市场:
SEHK
上市日期:
--
主营业务:
腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。该公司的产品应用于传染病(如乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)、多重耐药(MDR)或广泛耐药性(XDR)革兰氏阴性菌感染)及其他具有重大公共卫生负担的疾病(如中枢神经系统(CNS)疾病)。该公司还开发用于COVID-19等的疗法。
发行价格:
--
{"stockData":{"symbol":"02137","market":"HK","secType":"STK","nameCN":"腾盛博药-B","latestPrice":0.96,"timestamp":1724400507030,"preClose":0.97,"halted":0,"volume":1089500,"delay":0,"floatShares":730135230,"shares":730135230,"eps":-0.26312548,"marketStatus":"休市中","marketStatusCode":7,"change":-0.01,"latestTime":"08-23 16:08:27","open":0.98,"high":1.01,"low":0.94,"amount":1063410,"amplitude":0.072165,"askPrice":0.98,"askSize":20000,"bidPrice":0.96,"bidSize":9000,"shortable":0,"etf":0,"ttmEps":-0.39890058685669294,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"listingDate":1626105600000,"adjPreClose":0.97,"openAndCloseTimeList":[[1724376600000,1724385600000],[1724389200000,1724400000000]],"volumeRatio":1.2644894003246887,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02137/wiki","defaultTab":"wiki","newsList":[{"id":"2461399693","title":"腾盛博药-B盘中异动 早盘大幅上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461399693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461399693?lang=zh_cn&edition=full","pubTime":"2024-08-22 10:46","pubTimestamp":1724294771,"startTime":"0","endTime":"0","summary":"2024年08月22日早盘10时46分,腾盛博药-B股票出现波动,股价急速上涨5.21%。腾盛博药-B股票所在的生物技术行业中,整体跌幅为0.55%。消息层面,截至10时46分,腾盛博药-B股票正面舆情新闻比例11.11%。目前,腾盛博药的市值为7.01亿港元。该结果低于市场预期,导致腾盛博药股价连续两日大跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082210461198e35cab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082210461198e35cab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2461819582","title":"腾盛博药-B08月21日遭主力抛售72万元 环比增加800.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461819582","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461819582?lang=zh_cn&edition=full","pubTime":"2024-08-21 16:16","pubTimestamp":1724228208,"startTime":"0","endTime":"0","summary":"08月21日,腾盛博药-B股价收平报0.96元,成交金额162万元,换手率0.23%,振幅5.21%,量比3.85。腾盛博药-B今日主力资金净流出72万元,上一交易日主力净流出8万元,今日环比增加800.00%。该股主力净额占比0.10%,港股市场排名2615/2639。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082116180995add1d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082116180995add1d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2460738290","title":"腾盛博药上半年亏损近三亿,但公司表示“不慌”","url":"https://stock-news.laohu8.com/highlight/detail?id=2460738290","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460738290?lang=zh_cn&edition=full","pubTime":"2024-08-20 17:45","pubTimestamp":1724147109,"startTime":"0","endTime":"0","summary":"目前,腾盛博药的市值为7.01亿港元。2023年3月,腾盛博药主动叫停新冠中和抗体疗法生产。如今腾盛博药的乙肝管线主要来自于早期的“买买买”。腾盛博药表示,如今的现金足以支持其运营至2027年。乙肝产品是腾盛博药的研发重点,目前市场对该产品最终能否商业化态度不一。该结果低于市场预期,导致腾盛博药股价连续两日大跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082017455695aa610f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082017455695aa610f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2460019057","title":"《业绩》腾盛博药(02137.HK)中期亏损扩至2.81亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2460019057","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460019057?lang=zh_cn&edition=full","pubTime":"2024-08-20 01:51","pubTimestamp":1724089860,"startTime":"0","endTime":"0","summary":"腾盛博药-B(02137.HK) 公布6月止六个月中期业绩,亏损由上年同期1.9亿人民币(下同),扩至2.81亿元,每股亏损38分。不派中期息。期内并无产生收益。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/03/22末期业绩无派息2023/08/22中期业绩无派息2023/03/24末期业绩无派息 2022/08/24中期业绩无派息 AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211011124343160_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211011124343160_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1372917/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02137","BK1574","BK1161","BK1587"],"gpt_icon":0},{"id":"2460080800","title":"腾盛博药-B(02137)发布中期业绩 股东应占亏损2.81亿元 同比扩大47.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460080800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460080800?lang=zh_cn&edition=full","pubTime":"2024-08-19 19:40","pubTimestamp":1724067608,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B(02137)发布截至2024年6月30日止六个月的中期业绩,该集团期内未取得收益,股东应占亏损2.81亿元,同比扩大47.71%;每股基本亏损0.38元。公告称,亏损增加主要归因于主要与金融资产公允价值亏损有关的其他亏损1.15亿元,部分被研发开支及行政开支减少所抵销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1166462.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02137","BK1574","BK1587"],"gpt_icon":0},{"id":"2460080358","title":"腾盛博药-B(02137.HK)中期亏损扩大至2.83亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460080358","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460080358?lang=zh_cn&edition=full","pubTime":"2024-08-19 19:36","pubTimestamp":1724067396,"startTime":"0","endTime":"0","summary":"截至2024年6月30日止六个月,研发开支为人民币126.2百万元,与截至2023年6月30日止六个月的人民币202.2百万元相比,减少人民币76.0百万元或37.6%。截至2024年6月30日止六个月,期内亏损为人民币283.2百万元,与截至2023年6月30日止六个月的人民币196.8百万元相比,增加人民币86.4百万元或43.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819193636ab5e666b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819193636ab5e666b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1574","BK1161","BK1587"],"gpt_icon":0},{"id":"2460706029","title":"腾盛博药-B盘中异动 下午盘股价大涨5.26%报1.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460706029","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460706029?lang=zh_cn&edition=full","pubTime":"2024-08-19 15:22","pubTimestamp":1724052124,"startTime":"0","endTime":"0","summary":"2024年08月19日下午盘15时22分,腾盛博药-B股票出现异动,股价急速拉升5.26%。截至发稿,该股报1.000港元/股,成交量67.35万股,换手率0.09%,振幅8.42%。腾盛博药-B股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,科伦博泰生物-B、科笛-B、奥星生命科技涨幅较大,振幅较大的相关个股有圣诺医药-B、思路迪医药股份、百奥赛图-B,振幅分别为20.72%、16.71%、11.96%。消息层面,截至15时22分,腾盛博药-B股票正面舆情新闻比例100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081915220497199178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081915220497199178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1161","BK1587","BK1574"],"gpt_icon":0},{"id":"2457345745","title":"腾盛博药-B(02137.HK)拟8月19日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2457345745","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457345745?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:48","pubTimestamp":1722847697,"startTime":"0","endTime":"0","summary":"格隆汇8月5日丨腾盛博药-B(02137.HK)发布公告,董事会会议将于2024年8月19日(星期一)举行,藉以(其中包括)审阅及批准发布公司及其附属公司截至2024年6月30日止六个月的未经审核的中期业绩及其刊发,以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805164824957e892b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805164824957e892b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","02137","BK1574"],"gpt_icon":0},{"id":"2457177137","title":"腾盛博药-B盘中异动 临近收盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457177137","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457177137?lang=zh_cn&edition=full","pubTime":"2024-08-05 15:57","pubTimestamp":1722844667,"startTime":"0","endTime":"0","summary":"2024年08月05日临近收盘15时57分,腾盛博药-B股票出现波动,股价急速下挫5.05%。截至发稿,该股报0.940港元/股,成交量75.8万股,换手率0.10%,振幅6.06%。腾盛博药-B股票所在的生物技术行业中,整体涨幅为0.18%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080515574896823d6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080515574896823d6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2455944275","title":"腾盛博药-B盘中异动 急速拉升6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455944275","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455944275?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:37","pubTimestamp":1722393423,"startTime":"0","endTime":"0","summary":"2024年07月31日早盘10时37分,腾盛博药-B股票出现波动,股价快速拉升6.06%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。腾盛博药-B股票所在的生物技术行业中,整体涨幅为1.24%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731103703af94fc19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731103703af94fc19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1587","BK1161"],"gpt_icon":0},{"id":"2455910149","title":"腾盛博药(02137):合作伙伴VBI启动重组程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2455910149","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455910149?lang=zh_cn&edition=full","pubTime":"2024-07-31 09:02","pubTimestamp":1722387772,"startTime":"0","endTime":"0","summary":"金吾财讯 | 腾盛博药 公告,于2024年7月30日,公司的合作伙伴VBI Vaccines Inc.已根据经修订的《公司债权人安排法》启动重组程序。公司预计,VBI的破产对公司运营及财务状况影响甚微。公司依然拥有于2023年7月6日获得的BRII-179全球独家许可及PreHevbri亚太地区权益,并已为所有计划中涉及BRII-179的临床研究确保了临床供应。公司自2024年2月起一直与VBI密切合作,计划将BRII-179的生产责任转移给第三方合同开发和制造商,目前该计划在继续实施中。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NzBjNjFmNjI4ZDIyNTQ0NjcwODk0MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzBjNjFmNjI4ZDIyNTQ0NjcwODk0MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1941362","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137","BK1161","BK1587","BK1574"],"gpt_icon":0},{"id":"2455914397","title":"腾盛博药(02137.HK)合作伙伴VBI启动重组程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2455914397","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455914397?lang=zh_cn&edition=full","pubTime":"2024-07-31 08:19","pubTimestamp":1722385140,"startTime":"0","endTime":"0","summary":"腾盛博药(02137.HK) 公布,其合作伙伴VBI Vaccines已根据经修订的《公司债权人安排法》启动重组程序。公司预计,VBI的破产对公司营运及财务状况影响甚微。公司依然拥有于去年7月6日获得的BRII-179全球独家许可及PreHevbri亚太地区(日本除外)权益,并已为所有计划中涉及BRII-179的临床研究确保临床供应。此外,公司自今年2月起一直与VBI密切合作,计划将BRII-179的生产责任转移给第三方合同开发和制造商,目前该计划在继续实施中。因此,BRII-179的开发预计亦不会受该程序影响。(jl/cy)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211011124343160_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211011124343160_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1367603/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02137","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2455291906","title":"【腾盛博药-B(02137.HK)预计VBI的破产对公司运营及财务状况影响甚微】智通财经APP讯,腾盛博药-B(02137.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455291906","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455291906?lang=zh_cn&edition=full","pubTime":"2024-07-31 08:03","pubTimestamp":1722384213,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","BK1574","02137","BK1161"],"gpt_icon":0},{"id":"2455194989","title":"腾盛博药-B(02137)预计VBI的破产对公司运营及财务状况影响甚微","url":"https://stock-news.laohu8.com/highlight/detail?id=2455194989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455194989?lang=zh_cn&edition=full","pubTime":"2024-07-31 08:03","pubTimestamp":1722384213,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B 发布公告,于2024年7月30日,该公司的合作伙伴VBI Vaccines Inc.已根据经修订的《公司债权人安排法》启动重组程序。此外,参见公司2024年2月14日的公告,公司自2024年2月起一直与VBI密切合作,计划将BRII-179的生产责任转移给第三方合同开发和制造商,目前该计划在继续实施中。因此,BRII-179的开发预计亦不会受该程序影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02137","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2455674773","title":"腾盛博药-B盘中异动 下午盘股价大跌7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455674773","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455674773?lang=zh_cn&edition=full","pubTime":"2024-07-30 14:03","pubTimestamp":1722319382,"startTime":"0","endTime":"0","summary":"2024年07月30日下午盘14时03分,腾盛博药-B股票出现波动,股价快速跳水7.62%。截至发稿,该股报0.970港元/股,成交量60.9万股,换手率0.08%,振幅6.67%。腾盛博药-B股票所在的生物技术行业中,整体跌幅为0.02%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073014030396821844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073014030396821844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","02137","BK1161"],"gpt_icon":0},{"id":"2453048686","title":"腾盛博药-B盘中异动 早盘股价大跌5.70%报1.010港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453048686","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453048686?lang=zh_cn&edition=full","pubTime":"2024-07-24 10:37","pubTimestamp":1721788664,"startTime":"0","endTime":"0","summary":"2024年07月24日早盘10时37分,腾盛博药-B股票出现波动,股价快速下跌5.70%。截至发稿,该股报1.010港元/股,成交量9.3万股,换手率0.01%,振幅1.87%。资金方面,该股资金流入0港元,流出9.489万港元。腾盛博药-B股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,华康生物医学、金斯瑞生物科技、歌礼制药-B涨幅较大,振幅较大的相关个股有华康生物医学、荃信生物-B、科济药业-B,振幅分别为20.00%、16.85%、12.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407241037449681fa32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407241037449681fa32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","02137","BK1161"],"gpt_icon":0},{"id":"2452415330","title":"腾盛博药-B盘中异动 下午盘急速下挫5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452415330","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452415330?lang=zh_cn&edition=full","pubTime":"2024-07-19 13:00","pubTimestamp":1721365241,"startTime":"0","endTime":"0","summary":"2024年07月19日下午盘13时00分,腾盛博药-B股票出现异动,股价急速跳水5.49%。腾盛博药-B股票所在的生物技术行业中,整体跌幅为0.80%。其相关个股中,创胜集团-B、中国抗体-B、科笛-B涨幅较大,振幅较大的相关个股有维亚生物、盛禾生物-B、百奥赛图-B,振幅分别为11.32%、10.92%、9.40%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407191300419681e5e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407191300419681e5e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1161","BK1587"],"gpt_icon":0},{"id":"2452812972","title":"腾盛博药-B盘中异动 大幅拉升6.44%报1.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452812972","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452812972?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:05","pubTimestamp":1721181921,"startTime":"0","endTime":"0","summary":"2024年07月17日早盘10时05分,腾盛博药-B股票出现异动,股价快速拉升6.44%。截至发稿,该股报1.140港元/股,成交量20.25万股,换手率0.03%,振幅4.67%。资金方面,该股资金流入19.7815万港元,流出1.0355万港元。腾盛博药-B股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,金斯瑞生物科技、腾盛博药-B、科济药业-B涨幅较大,振幅较大的相关个股有盛禾生物-B、维亚生物、嘉和生物-B,振幅分别为16.10%、7.69%、7.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717100521941f7a75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717100521941f7a75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","02137","BK1161"],"gpt_icon":0},{"id":"2452974730","title":"腾盛博药-B(02137)股价上升5.607%,现价港币$1.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2452974730","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452974730?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:05","pubTimestamp":1721181900,"startTime":"0","endTime":"0","summary":"[上升股]腾盛博药-B(02137) 股价在上午10:05比前收市价上升5.607%,现股价为港币$1.13。至目前为止,今日最高价为$1.13,而最低价为$1.09。总成交量为19.7万股,总成交金额为港币$21.982万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240717535/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1587","02137","BK1574","BK1161"],"gpt_icon":0},{"id":"2450487377","title":"腾盛博药-B(02137)上涨9.0%,报1.09元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450487377","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450487377?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:47","pubTimestamp":1720770424,"startTime":"0","endTime":"0","summary":"7月12日,腾盛博药-B(02137)盘中上涨9.0%,截至15:47,报1.09元/股,成交115.61万元。腾盛博药生物科技有限公司主要业务是针对未被满足的病人需求和有限的治疗手段,开发针对感染性疾病和中枢神经系统疾病的创新疗法。该公司成立于2018年,现业务遍布罗利-达勒姆、旧金山湾区和中国的北京与上海,于2021年在香港交易所挂牌上市,股票代码为2137.HK。截至2023年年报,腾盛博药-B营业总收入61.7万元、净利润-1.75亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/12154741537581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","02137","BK1587","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.briibio.com","stockEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0495},{"period":"3month","weight":-0.2441},{"period":"6month","weight":-0.4667},{"period":"1year","weight":-0.6678},{"period":"ytd","weight":-0.5789}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.0174},{"period":"3month","weight":-0.0536},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0329},{"period":"ytd","weight":0.0331}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。该公司的产品应用于传染病(如乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)、多重耐药(MDR)或广泛耐药性(XDR)革兰氏阴性菌感染)及其他具有重大公共卫生负担的疾病(如中枢神经系统(CNS)疾病)。该公司还开发用于COVID-19等的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.139084},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.166803},{"month":3,"riseRate":0,"avgChangeRate":-0.321072},{"month":4,"riseRate":0.333333,"avgChangeRate":0.044149},{"month":5,"riseRate":0,"avgChangeRate":-0.067206},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.097476},{"month":7,"riseRate":1,"avgChangeRate":0.066427},{"month":8,"riseRate":0.25,"avgChangeRate":0.016621},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.121948},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.120095},{"month":11,"riseRate":1,"avgChangeRate":0.511244},{"month":12,"riseRate":0,"avgChangeRate":-0.197537}],"exchange":"SEHK","name":"腾盛博药-B","nameEN":"BRII - B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"腾盛博药-B,02137,腾盛博药-B股票,腾盛博药-B股票老虎,腾盛博药-B股票老虎国际,腾盛博药-B行情,腾盛博药-B股票行情,腾盛博药-B股价,腾盛博药-B股市,腾盛博药-B股票价格,腾盛博药-B股票交易,腾盛博药-B股票购买,腾盛博药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}